Akari Therapeutics (AKTX) Institutional Ownership → Have You Seen Elon’s New A.I. Device? (Picture Inside) (From InvestorPlace) (Ad) Free AKTX Stock Alerts $1.55 -0.15 (-8.82%) (As of 12:08 PM ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for Akari Therapeutics (NASDAQ:AKTX)CurrentInstitutional OwnershipPercentage5.06%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$88.95KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$28.50M Get AKTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Akari Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data AKTX Institutional Buying and Selling by Quarter Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. Akari Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/5/2024 Omnia Family Wealth LLC87,628$273K0.1%+48.2%1.551% 11/15/2023Sabby Management LLC178,091$703K0.5%-97.6%3.152% 11/14/2022Armistice Capital LLC4,290,000$2.70M0.0%N/A5.762% 10/27/2022 Omnia Family Wealth LLC782,372$493K0.4%+3.2%1.051% 5/6/2022 Omnia Family Wealth LLC758,144$910K0.6%+13.7%1.277% 4/13/2022Hikari Power Ltd130,821$157K0.0%+45.7%0.220% Get the Latest News and Ratings for AKTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Akari Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 2/10/2022Wsfs Capital Management LLC100,000$150K0.1%N/A0.193% 2/4/2022 Omnia Family Wealth LLC667,085$1.00M0.6%+42.8%1.285% 8/13/2021Renaissance Technologies LLC151,396$262K0.0%+14.0%0.318% 8/6/2021HighTower Advisors LLC26,000$45K0.0%N/A0.055% 8/3/2021 Omnia Family Wealth LLC467,085$808K0.5%+12.1%0.981% 5/21/2021Citadel Advisors LLC27,712$73K0.0%N/A0.175% 5/18/2021Citadel Advisors LLC27,712$73K0.0%N/A0.175% 5/17/2021HRT Financial LP16,087$42K0.0%N/A0.101% 5/13/2021Renaissance Technologies LLC132,751$350K0.0%+23.3%0.837% 5/12/2021Geode Capital Management LLC30,264$79K0.0%N/A0.191% 5/12/2021 Omnia Family Wealth LLC416,584$1.10M0.8%+6.4%2.627% 2/16/2021Endurant Capital Management LP206,561$382K0.1%N/A1.303% 2/10/2021HighTower Advisors LLC26,000$49K0.0%+62.5%0.164% 11/3/2020 United Asset Strategies Inc.286,611$499K0.1%-4.5%1.807% 10/20/2020Wedbush Securities Inc.31,381$55K0.0%N/A0.198% 10/8/2020Hikari Power Ltd89,815$156K0.0%-94.0%0.566% 8/28/2020PNC Financial Services Group Inc.12,000$26K0.0%N/A0.076% 8/7/2020Virtu Financial LLC18,129$40K0.0%N/A0.114% 8/7/2020PNC Financial Services Group Inc.12,000$26K0.0%N/A0.076% 8/3/2020 United Asset Strategies Inc.300,000$654K0.1%N/A1.892% 5/5/2020 Omnia Family Wealth LLC184,258$267K0.3%+8.6%1.162% (Data available from 1/1/2016 forward) AKTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of AKTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Akari Therapeutics shares: Armistice Capital LLC ($2.70M), and Sabby Management LLC ($703K), Omnia Family Wealth LLC ($273K).Learn more on AKTX's institutional investors. What percentage of Akari Therapeutics stock is owned by institutional investors? 5.06% of Akari Therapeutics stock is owned by institutional investors. Learn more on AKTX's institutional investor holdings. Which institutional investors have been buying Akari Therapeutics stock? The following institutional investors have purchased Akari Therapeutics stock in the last 24 months: Armistice Capital LLC ($4.29M), and Omnia Family Wealth LLC ($143.80K). How much institutional buying is happening at Akari Therapeutics? Institutional investors have bought a total of 4,433,798 shares in the last 24 months. This purchase volume represents approximately $56.63M in transactions. Which Akari Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Akari Therapeutics stock in the last 24 months: Sabby Management LLC ($7.21M). How much institutional selling is happening at Akari Therapeutics? Institutional investors have sold a total of 7,214,040 shares in the last 24 months. This volume of shares sold represents approximately $28.50M in transactions. Related Companies: Elevai Labs Institutional Ownership AgeX Therapeutics Institutional Ownership MIRA Pharmaceuticals Institutional Ownership RedHill Biopharma Institutional Ownership Monopar Therapeutics Institutional Ownership Purple Biotech Institutional Ownership Moleculin Biotech Institutional Ownership Kiora Pharmaceuticals Institutional Ownership Molecular Templates Institutional Ownership Galera Therapeutics Institutional Ownership This page (NASDAQ:AKTX) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersAI finds its first serious applicationWall Street StarRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsA once-in-a-century investment opportunityStansberry ResearchProtect Your Bank Account Before It’s Too LateWeiss RatingsYour bank is lying to you.MyBankTracker Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Akari Therapeutics, Plc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
